Skip to main content

Meyer Colin John's Form 4 filing

Reata Pharmaceuticals IncRETA · filed Mar 6, 2023

Accession no.
0001209191-23-016380
Filed
Mar 6, 2023
Trade date
Mar 2-3, 2023
Filing delay
4 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 7 non-derivative transactions and 3 derivative transactions. Open-market sales total $8.15M. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Meyer Colin JohnCIK 0001662392Officer (Chief Innovation Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Mar 2, 2023Class A common stockCConversionAcquired+88,636–F1–179,149Direct
Mar 2, 2023Class A common stockSSaleDisposed−22,752$85.23F2−$1,939,152.96156,397Direct
Mar 2, 2023Class A common stockSSaleDisposed−34,794$86.49F3−$3,009,333.06121,603Direct
Mar 2, 2023Class A common stockSSaleDisposed−19,099$87.55F4−$1,672,117.45102,504Direct
Mar 2, 2023Class A common stockSSaleDisposed−11,181$88.50F5−$989,518.591,323Direct
Mar 2, 2023Class A common stockSSaleDisposed−810$90.58F6−$73,369.890,513Direct
Mar 3, 2023Class A common stockSSaleDisposed−5,286$87.35F8−$461,732.185,227Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Mar 2, 2023Class B common stockMOption exerciseDisposed−88,636$0.00$00Direct
Mar 2, 2023Class A common stockMOption exerciseAcquired+88,636$11.00+$974,996162,940Direct
Mar 2, 2023Class A common stockCConversionDisposed−88,636–F1–74,304Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date.

Referenced by the price of 1 transaction in Table I and 1 transaction in Table II.

F2

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $85.00 to $85.99. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

F3

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $86.00 to $86.99. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

F4

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $87.00 to $87.98. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

F5

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $88.00 to $89.80. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

F6

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $90.03 to $90.99. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

F8

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $87.35 to $87.36. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)